Researchers at the Johns Hopkins University School of Medicine have mapped variation in human stem cells that explains how cells of an individual may shape a unique developmental dance at the molecular level, thereby controlling how the brain and body are created. The findings further our understanding of the origins and implications of cellular variation in people and may advance the design of individualized therapeutics and methods to rebuild diseased or damaged human organs.
The study, published Sep. 10 in Stem Cell Reports, used human induced pluripotent stem cells a type of stem cell that are equivalent to cells in early embryonic development that can develop multiple types of tissue. Studying pluripotent cells from several donors showed how genetic and epigenetic (nonnuclear DNA) factors contribute to individual variation in early brain development.
The entirety of each individual human body is created from a single cell, and as cells of the developing embryo begin to divide, they perform genetically programmed choreography to construct the new human, says Carlo Colantuoni, Ph.D., assistant professor in the departments of neurology and neuroscience at the Johns Hopkins University School of Medicine.
But, notes Colantuoni, while this developmental dance has major steps that are consistent across the human population (and the animal kingdom), this study has uncovered molecular patterns and gene expression traits that modify the conserved human steps and create unique individual development.
In this study, researchers at The Johns Hopkins University and Yale University used a process known as cellular reprogramming, in which mature cells can revert to their embryonic pluripotent status a technique that won a Nobel Prize in 2012. Specifically, the researchers took skin cells from adult humans and returned them to an early embryonic state. Called induced pluripotent stem cells (iPSCs), they have the potential to develop into any human body cell.
Researchers let the iPSCs grow and interact unconstrained, enabling cells to reveal their inherent nature and individuality. RNA sequencing, which examines how much RNA is being produced from each gene, gave researchers a detailed molecular perspective on what the cells were doing. Then, by combining the RNA data from iPSCs with data from developing mouse embryos, the researchers mapped variation of the donors cells onto the landscape of mammalian development. This allowed observation of systematic differences in how individual human cells navigate early development differences also observed in public data from 100 human stem cell donors.
Researchers saw two types of patterns, or rhythms, of the developmental dance emerge from the RNA data. The first type of pattern was consistent across all individual donors, defining large modules responsible for creating elements of the human body such as the brain, heart and liver. Patterns of the second type were more subtle, newer in evolutionary terms and present only in the cells of specific individuals regardless of the final function of the cells.
Notably, the newer patterns that show individual variation in the human programmed choreography were present not only in the cells observed in the laboratory, but also in the mature cells of the donors bodies. The researchers say this indicates that the variations they saw in cellular development, each specific to an individual person, influenced the steps the donor cells took during early development.
By logical extension, the scientists say, their findings not only indicate the unique steps an individuals cells take, but also that these cells hold information about the health or risk of diseases of a person over their lifetime. Colantuoni says these insights may pave the way for individualized approaches in regenerative medicine that are more precise.
We advocate studying induced pluripotent stem cells and their derivatives to understand each patients risk for complex disease and specific treatments that will be most effective for that individual, says Colantuoni. We see a future in which a patients traditional medical history, genome sequence and living cells are routinely used together to diagnose and customize treatment for patients.
Colantuoni says scientists are just beginning to uncover the specific molecular mechanisms underlying differences in human cellular development. More studies with larger and more varied donor pools are needed to understand the long-term health impacts of an individuals developing cells dancing to the beat of their own drum.
Other scientists who have contributed to this research are Suel-Kee Kim, Seungmae Seo, Genevieve Stein-OBrien, Amritha Jaishankar, Kazuya Ogawa, Nicola Micali, Yanhong Wang, Thomas Hyde, Joel Kleinman, Elana Fertig, Joo Heon Shin, Daniel Weinberger, Joshua Chenoweth, Daniel Hoeppner and Ronald McKay.
Funding for this research was provided by NCI/NIH grants R01CA177669, P30CA006973, U01CA212007 and U01CA253403, and the Johns Hopkins University Catalyst Award won by EJF R01NS116418, R01HG010898, MH116488 and U01MH124619, awarded to N.S. Data sharing and visualization via NeMO Analytics, were supported by grants R24MH114815 and R01DC019370.
Originally posted here:
New Study Mapping Stem Cells Reveals Molecular Choreography Behind ...
- From head to tail: How cells can behave autonomously during early development - Phys.org - November 20th, 2024
- Cooperative role of LSD1 and CHD7 in regulating differentiation of mouse embryonic stem cells - Nature.com - November 18th, 2024
- The emergence of Sox and POU transcription factors predates the origins of animal stem cells - Nature.com - November 18th, 2024
- Genes of ancient animal relatives used to grow a mouse: Study reveals hidden history of stem cells - Phys.org - November 18th, 2024
- MD Anderson Cancer Center unveils cell therapy research institute that will work with biotech, pharma - Fierce Biotech - November 12th, 2024
- Stem cell transplantation extends the reproductive life span of naturally aging cynomolgus monkeys - Nature.com - November 10th, 2024
- Embryonic stem cells - PMC - November 8th, 2024
- Thermo Fisher and Novo Nordisk Foundation Cellerator Unite to Revolutionize Cell Therapy Manufacturing - Healthcare Digital - November 8th, 2024
- RMS Sponsors the 5th Summit on Stem Cell Derived Islets - The Manila Times - October 30th, 2024
- Differentiation fate of a stem-like CD4 T cell controls immunity to cancer - Nature.com - October 30th, 2024
- Self-organization of stem cells into embryos: A window on early ... - October 24th, 2024
- Stemness and ROS: Redox Signaling and Regulation in Stem Cell Biology - Frontiers - October 24th, 2024
- Now its getting bloody in cardiac organoids - Nature.com - October 18th, 2024
- Embryonic stem cells - PMC - National Center for Biotechnology Information - October 15th, 2024
- They Were Made Without Eggs or Sperm. Are They Human? - The Atlantic - October 15th, 2024
- A novel investigation of NANOG and POU5F1 associations in the pluripotent characterization of ES-like and epiblast cells - Nature.com - October 15th, 2024
- Researchers uncover new mechanism of stem cell differentiation linked to cancer progression - News-Medical.Net - October 14th, 2024
- Stem Cells to Reverse Diabetes, the Spread of Marburg Virus and Map of a Fruit Fly Brain - Scientific American - October 14th, 2024
- Stem Cells Market Expectation Surges with Rising Demand and Changing Trends - openPR - October 11th, 2024
- How close are we to perfecting synthetic stem cells? - The Mancunion - October 10th, 2024
- Blood-generating heart-forming organoids recapitulate co-development of the human haematopoietic system and the embryonic heart - Nature.com - October 10th, 2024
- Revolutionary stem cell transplant successfully closes vision-threatening holes in the eye - Study Finds - October 4th, 2024
- Early human development and stem cell-based human embryo models - October 4th, 2024
- No partner, no problem: How people in the future might be able to have children with themselves - RNZ - October 4th, 2024
- Californias Billion-Dollar Stem Cell Initiatives End In Failure OpEd - Eurasia Review - October 4th, 2024
- The Future Of Stem Cell Therapy With Dr Adeel Khan - Style Magazines - October 4th, 2024
- Stem Cell Research at Johns Hopkins Institute of Basic Biomedical ... - September 30th, 2024
- Zack Wang , PhD - Hopkins Medicine - September 30th, 2024
- Jennifer Hartt Elisseeff , PhD - Hopkins Medicine - September 30th, 2024
- Dr. Elias Zambidis, MD, PhD - Baltimore, MD - Pediatric Cellular ... - September 30th, 2024
- Alan David Friedman , MD - Hopkins Medicine - September 30th, 2024
- Targeted therapy of cancer stem cells: inhibition of mTOR in pre-clinical and clinical research - Nature.com - September 30th, 2024
- Human Embryonic Stem Cells Market Insights and Growth Trends: Leading Players and Future Projections to 2031 - WhaTech - September 26th, 2024
- Zac Efron says stem cell therapy helped him heal from The Iron Claw injuries - Daily Mail - September 25th, 2024
- The Role of Stem Cell Therapy in the Future of Personalized Medicine - HIT Consultant - September 25th, 2024
- Stem Cell Therapy Market to Exceed $831.9 Million by 2032 with 17.2% CAGR Growth - openPR - September 14th, 2024
- Brain Builders: How Stem Cell Research Is Rewriting the Genetic Code of Mental Health - SciTechDaily - September 14th, 2024
- Pausing biological clock could give boost to lab-produced blood stem cells - Phys.org - September 10th, 2024
- Alive and Kicking: Watch this space on controversy-free stem-cell ... - September 8th, 2024
- After 25 years of hype, embryonic stem cells still don't cure for ... - September 8th, 2024
- Human embryonic stem cells: origin, properties and applications - September 8th, 2024
- Livestock embryonic stem cells for reproductive biotechniques and ... - September 8th, 2024
- Marinexcell: Our Vision Is To Create a Sustainable and Reliable Source of Seafood Products - vegconomist - the vegan business magazine - September 6th, 2024
- How cells enter the germline at the right time and place during embryonic development - MRC Laboratory of Molecular Biology - September 6th, 2024
- Diabetes took over her life, until a stem cell therapy freed her - redlakenationnews.com - August 31st, 2024
- Diabetes took over her life, until a stem cell therapy freed her - The Washington Post - August 27th, 2024
- New way to extend shelf life of blood stem cells will improve gene therapy - University of Cambridge news - August 20th, 2024
- The anti-aging tech guy is now shooting $25,000 worth of stem cells into his knees. Here's why - Quartz - August 16th, 2024
- Substrates mimicking the blastocyst geometry revert pluripotent stem cell to naivety - Nature.com - August 12th, 2024
- Delivery of stem cell therapy for Parkinsons safe in primate trial - Parkinson's News Today - August 2nd, 2024
- Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program - July 31st, 2024
- Atea Pharmaceuticals to Host Second Quarter 2024 Financial Results Conference Call on August 7, 2024 - July 31st, 2024
- Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update - July 31st, 2024
- PolyPid to Report Second Quarter 2024 Financial Results and Operational Highlights on August 14, 2024 - July 31st, 2024
- Kymera Therapeutics to Report Second Quarter 2024 Financial Results on August 7 - July 31st, 2024
- Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2024 - July 31st, 2024
- Paratek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacycline) Demonstrating No Change in In Vitro Potency... - July 31st, 2024
- Ocular Therapeutix™ to Report Second Quarter 2024 Financial Results on August 7, 2024 - July 31st, 2024
- Appendix 4C – Q4 FY24 Quarterly Cash Flow Report - July 31st, 2024
- Regeneron Announces the 2024 Winners of the Regeneron Prize for Creative Innovation - July 31st, 2024
- Clearmind Medicine Concludes the Successful Participation in the Psychedelic Medicine – Israel 2024 Conference: Presented Industry Leaders its... - July 31st, 2024
- Milestone® Pharmaceuticals to Present at the Upcoming BTIG Virtual Biotechnology Conference - July 31st, 2024
- Fate Therapeutics Appoints Neely Mozaffarian, MD, PhD, FACR, to its Board of Directors - July 31st, 2024
- electroCore to Announce Second Quarter June 30, 2024 Financial Results on Wednesday, August 7, 2024 - July 31st, 2024
- GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339 - July 31st, 2024
- New Study: These Bizarre Blood-Sucking Fish Have a Jaw-Dropping Evolutionary Origin - SciTechDaily - July 30th, 2024
- Surgeon Turns to Stem Cells to Help Treat Autism and Immune Disorders - The Well News - July 22nd, 2024
- Study identifies epigenetic 'switches' that regulate the developmental trajectories of single cells - Medical Xpress - July 22nd, 2024
- German Man Likely 'Cured' of HIV With Stem Cell Therapy - Times Now - July 22nd, 2024
- CervoMed to Participate in the Emerging Growth Conference - July 18th, 2024
- Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives - July 18th, 2024
- Kane Biotech Receives ISO 13485:2016 MDSAP Quality Certification - July 18th, 2024
- Scilex Holding Company Announces Collaboration to Leverage ACEA Therapeutics’ R&D Expertise and Local Market Connections to Support the Expansion of... - July 18th, 2024
- Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of... - July 18th, 2024
- Roche’s Vabysmo showed extended durability, continued efficacy and a consistent safety profile in long-term diabetic macular edema (DME) study - July 18th, 2024
- New Nature publication confirms CARBIOS’ leadership in enzymatic degradation of plastic - July 18th, 2024
- Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series Completion - July 18th, 2024
- Promising Preliminary Results in Optic Nerve Recovery Study of NurExone’s first product ExoPTEN for Glaucoma - July 18th, 2024
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal - July 18th, 2024
- Scorpius Holdings Announces Reverse Stock Split - July 18th, 2024
Recent Comments